Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzhou Novoprotein Scientific Co has a quick ratio of 22.33. It generally indicates good short-term financial strength.
The historical rank and industry rank for Suzhou Novoprotein Scientific Co's Quick Ratio or its related term are showing as below:
SHSE:688137'
s Quick Ratio Range Over the Past 10 Years
Min: 0.25 Med: 25.03 Max: 40.22
Current: 22.33
During the past 8 years, Suzhou Novoprotein Scientific Co's highest Quick Ratio was 40.22. The lowest was 0.25. And the median was 25.03.
SHSE:688137's Quick Ratio is ranked better than 93.9% of 1409
companies
in the Biotechnology industry
Industry Median: 3.59
vs SHSE:688137: 22.33
Suzhou Novoprotein Scientific Co (SHSE:688137) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Suzhou Novoprotein Scientific Co Quick Ratio Related Terms
Suzhou Novoprotein Scientific Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Novoprotein Scientific Co Quick Ratio Chart
SHSE:688137 vs VRTX, REGN, RVMD: Quick Ratio Comparison
For the Biotechnology subindustry, Suzhou Novoprotein Scientific Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Novoprotein Scientific Co Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Suzhou Novoprotein Scientific Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Suzhou Novoprotein Scientific Co's Quick Ratio falls into.
Suzhou Novoprotein Scientific Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Novoprotein Scientific Co (SHSE:688137) has a Quick Ratio of 22.33 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Suzhou Novoprotein Scientific Co and its competitors. This is 11% below median its historical median of 25.03. Over the past decade, Suzhou Novoprotein Scientific Co's Quick Ratio has ranged from 0.25 to 40.22. According to the industry distribution chart, Suzhou Novoprotein Scientific Co ranks #86 out of 1409 companies in the Biotechnology industry, placing it in the top 6.1%.
Is Suzhou Novoprotein Scientific Co's Quick Ratio too high?
Suzhou Novoprotein Scientific Co's current Quick Ratio of 22.33 is 11% below median its 10-year median of 25.03. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 40.22. The Biotechnology industry median Quick Ratio is 3.59. Suzhou Novoprotein Scientific Co's value of 22.33 is 522% above this industry median. Based on the distribution chart, Suzhou Novoprotein Scientific Co ranks #86 out of 1409 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Suzhou Novoprotein Scientific Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Novoprotein Scientific Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Suzhou Novoprotein Scientific Co ranks #86 out of 1409 companies for Quick Ratio. This places Suzhou Novoprotein Scientific Co in the top 6% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.59. Suzhou Novoprotein Scientific Co's value of 22.33 is 522% above this benchmark. Historically, Suzhou Novoprotein Scientific Co's own Quick Ratio has ranged from 0.25 to 40.22 over the past decade. While the company's 10-year median is 25.03 vs. the industry median of 3.59, Suzhou Novoprotein Scientific Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.59, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzhou Novoprotein Scientific Co's current Quick Ratio of 22.33 is 522% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Suzhou Novoprotein Scientific Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Novoprotein Scientific Co's current Quick Ratio is 22.33, which is 11% below median its own 10-year median of 25.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Novoprotein Scientific Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co (SHSE:688137) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.73, compared to a current price of ¥34.76 — trading 7.9% below its estimated fair value. The current Quick Ratio is 22.33, which is 11% below median its 10-year median of 25.03 and 522% above the Biotechnology industry median of 3.59. Suzhou Novoprotein Scientific Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Suzhou Novoprotein Scientific Co (SHSE:688137), the current Quick Ratio is 22.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzhou Novoprotein Scientific Co (SHSE:688137) Overvalued in 2026?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co stock appears to be undervalued.
The current stock price of ¥34.76 is trading 7.9% below its estimated GF Value™ of ¥37.73.
GuruFocus considers Suzhou Novoprotein Scientific Co to be Fairly Valued.
Key valuation signals for SHSE:688137:
Quick Ratio: 22.33 (11% below median its 10-year median of 25.03)
GF Value™: ¥37.73 vs. price of ¥34.76 (7.9% below fair value)
Industry Position: 522% above the Biotechnology median (#86 of 1409)
No single metric tells the full story. See the SHSE:688137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzhou Novoprotein Scientific Co Business Description
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes, and reagents, Production and sales, and providing related technical services.
62GF Score
Get the complete analysis for SHSE:688137
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688137 has been successfully added to your 
